Updated Interim Efficacy Analysis and Long-term Safety of Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Without Prior Chemotherapy (COU-AA-302).
Autor: | Rathkopf, Dana E.1 rathkopd@mskcc.org, Smith, Matthew R.2, de Bono, Johann S.3, Logothetis, Christopher J.4, Shore, Neal D.5, de Souza, Paul6, Fizazi, Karim7, Mulders, Peter F.A.8, Mainwaring, Paul9, Hainsworth, John D.10, Beer, Tomasz M.11, North, Scott12, Fradet, Yves13, Van Poppel, Hendrik14, Carles, Joan15, Flaig, Thomas W.16, Efstathiou, Eleni4, Yu, Evan Y.17, Higano, Celestia S.17, Taplin, Mary-Ellen18 |
---|---|
Zdroj: | European Urology. Nov2014, Vol. 66 Issue 5, p815-825. 11p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |